Using whole-cell voltage clamp electrophysiology, we first sought to investigate the effects of CaMKII modulation on the recurrent Nav1.6 gain-of-function epilepsy mutation R850Q (ClinVar VCV000135651) [16]. Here, CAMK2G is linked to epilepsy.